50 years of IBD in ESPGHAN Part 2: The big bang: How did biologics change the management of pediatric IBD
|
|
|
- Arline O’Brien’
- 5 years ago
- Views:
Transcription
1 Gastroenterology Upcoming biologics from the IBD pipeline - the small molecules era Chairs: Sanja Kolacek, Jorge Amil Dias 08:30 08:38 50 years of IBD in ESPGHAN Part 2: The big bang: How did biologics change the management of pediatric IBD Anders Paerregaard (Denmark) 08:38 09:01 Anti IL12/23 and anti-integrins Arie Levine (Israel) 09:01 09:11 Abstract: Safety of adalimumab in children and adolescents with moderate to severe Crohn s disease: Interim results of the CAPE registry Dan Turner (Israel) 09:11 09:34 Oral biologics: JAK inhibitors and (S1P) receptor modulator Anne Griffiths (Canada) 09:34 09:44 Abstract: Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort Richard Colletti (United States) 09:44 10:07 Are there even more future biological options? Matthieu Allez (France) 10:07 10:30 So many novel biologics for IBD... how to choose? Predictors of response Dan Turner (Israel)
2 08:30-08:55 Nutrition Infant feeding: past, present & future The ESPGHAN CoN and infant feeding: what can we learn from history? Chairs: Magnus Domellof, Falvia Indrio Olle Hernell (Sweden) 08:55 09:20 Protection and promotion of breastfeeding Laurence Grummer-Strawn (Switzerland) 09:20 09:30 Abstract: Adiponectin gene methylation status in breast versus formula fed infants Omneya Magdy Omar (Egypt) 09:30 09:55 How do we ensure infant foods are appropriate and safe? Dominique Turck (France) 09:55 09:05 Abstract: Safety of a modified, low protein infant formula in term infants; an RCT with a reference breast-fed group Stefanie Kouwenhoven (Netherlands) 10:05-10:30 Do young children need special formulas? Iva Hojsak (Croatia)
3 Hepatology Novelties in paediatric hepatology Chairs: Nedim Hadzic, Giuseppe Indolfi 08:30 09:03 New developments in diagnostic techniques Emmanuel Gonzales (France) 09:03 09:13 Abstract: Toxicological evaluation of a gene therapy approach for the treatment of Crigler-Najjar in rhesus macaques Jenny Greig (United States) 09:13 09:46 Diagnosis and treatment of ciliopathies Tassos Grammatikopoulos (UK) 09:46 09:56 Abstract: Hepatitis C virus infection in 663 European children, results of a web-based survey Giuseppe Indolfi (Italy) 09:56 10:29 Changing epidemiology of viral hepatitis Philippa Easterbrook (Switzerland)
4 Gastroenterology Challenges in Motility Chairs: Osvaldo Borrelli, Annamaria Staiano 08:30 08:38 50 years of the GI Motility in ESPGHAN Peter Milla (United Kingdom) 08:38 09:01 09:01 09:11 Is there a place for ph/impedance or oesophageal manometry in routine clinical care? Abstract: Clinical management of paediatric achalasia: a survey of current practice Michiel van Wijk (The Netherlands) Maartje Singendonk (Netherlands) 09:11 09:34 Belching, hiccups and aerophagia Daniel Sifrim (United Kingdom) 09:34 09:44 Abstract: Achalasia cardia subtypes on high resolution oesophageal manometry in children Anshu Srivastava (India) 09:44 10:07 Non-retentive fecal incontinence; diagnosis and treatment Marc Benninga (The Netherlands) 10:07 10:30 Constipation related fecal incontinence; what to do Nikhil Thapar (United Kingdom)
5 11:40 12:10 Nutrition Nutrition Keynote Chair: Mary Fewtrell 11:40 12:10 Nutrition in intestinal failure: past, present and future Olivier Goulet (France)
6 12:10 13:30 Nutrition Nutrition in the chronically ill child; key points and practical considerations Chairs: Sissel Moltu, Jiri Bronsky 12:10 12: 33 Nutrition in the child with cancer Evelyn Ward (United Kingdom) 12:33 12:43 Abstract: Can weight equations help us to avoid weighing neurologically impaired children and adolescents? Koen Huysentruyt (Belgium) 12:43 13:06 Nutrition in the child with cystic fibrosis Jessie Hulst (The Netherlands) 13:06 13:29 Nutrition in the child with congenital heart disease Luise Marino (United Kingdom)
7 12:10 13:40 Gastroenterology Plenary Session 2 Chairs: Carmen Ribes Koninckx, Yvan Vandenplas 12:10 12: 20 12:20 12:30 12:30 12:40 12:40 12:50 12:50 13:00 13:00 13:10 13:10 13:20 13:20 13:30 Intestinal anti-tissue transglutaminase antibodies to simplify celiac disease diagnosis Differentiation of Colonic IBD: Re-examination of Porto algorithm with resected colon as gold standard A randomized controlled trial comparing six-food elimination diet vs topical steroids in inducing and maintaining remission of paediatric eosinophilic esophagitis Cognitive debriefing interviews (phase 2B) towards developing a patient reported outcome for pediatric Ulcerative Colitis- the TUMMY-UC Long-term maintenance therapy with the lowest effective dose of oral viscous budesonide in paediatric eosinophilic esophagitis Faecal calprotectin levels before and after exclusive and maintenance enteral nutrition in patients with active Crohn's disease. A dose-dependent effect of maintenance enteral nutrition? Prospective evaluation of intestinal damage in the development of coeliac disease in the PreventCD cohort using circulating intestinal fatty acid binding protein Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort Fabiana Ziberna (Italy) Jasbir Dhaliwal (Canada) Salvatore Oliva (Italy) Dan Turner (Israel) Salvatore Oliva (Italy) Michael Logan (United Kingdom) Johanna Kreutz (Netherlands) Richard Colletti (United States)
8th EUROPEAN GI MOTILITY MEETING Thursday 22 nd Saturday 24 th March 2018
Thursday 22 nd March 2018 12.30 14.25 Registration and Lunch 14.25 14.30 Welcome to PEDMOT 2018 Dr Nikhil Thapar, Great Ormond Street Hospital & University College of London, London, UK Session: Pharynx
PEDIATRIC INFLAMMATORY BOWEL DISEASE
PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease
Nutrition Summer School 2007
ESPGHAN EUROPEAN SOCIETY FOR PAEDIATRIC GASTROENTEROLOGY HEPATOLOGY AND NUTRITION COMMITTEE OF NUTRITION Nutrition Summer School 2007 Nutrition and Immunity Cavtat, Dubrovnik Croatia 22-27 September 2007
PIBD IN BARCELONA 2017
PIBD IN BARCELONA 2017 The fourth International symposium on paediatric IBD PIBD was held in Barcelona, 13th - 17th of September 2017. It attracted 527 delegates from 57 countries and 5 continents to come
Outline. Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic. Biologic Drugs. Biologic Drugs. Biologic Drugs Anti-TNF
Outline Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic Types of biologic drugs How do they work? How effective are they? Safety/Toxicity concerns with biologics Biologic
Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG
Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.
GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint
GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Gastroenterology MOC exam blueprint Based on feedback from physicians that MOC assessments
NEURO- GASTRO- ENTEROLOGY & MOTILITY OESO- PHAGUS LOGY. Room A Room B Room C Room E1 Room E2 Room M Room N1 Room N2 Room L8 Room 1.
ONCO ENTERO RADIO & SATURDAY SUNDAY MONDAY TUESDAY WEDNESDAY Saturday, October 15, 2016 Room A Room B Room C Room E1 09:00-10:30 Peptic ulcer : Still important for gastroenterologists 11:00-13:00 Video
Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R.
UvA-DARE (Digital Academic Repository) Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R. Link to publication Citation for published version
Pediatric Gastroenterology Referral Guidelines
Suggested Pre-Referral Workup This is a general suggestion of possible testing to confirm a suspected diagnosis. Although referrals will be accepted without the suggested work up being complete, to ensure
Gastroenterology. Certification Examination Blueprint. Purpose of the exam
Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist
ESPEN Congress Lisbon 2015 NUTRITIONAL ISSUES IN CROHN'S DISEASE. The clash of generations: children are not small adults S.
ESPEN Congress Lisbon 2015 NUTRITIONAL ISSUES IN CROHN'S DISEASE The clash of generations: children are not small adults S. Kolacek (HR) Role of Nutrition in Children with CD Child is NOT a Little Adult
Technologies scoping report
Technologies scoping report In response to an enquiry from NHS Greater Glasgow and Clyde Number 18 October 2013 What is the clinical effectiveness, cost effectiveness and implications for safety of assessing
Research Update: Looking for the Answers
Research Update: Looking for the Answers Ted Denson, M.D. Schubert-Martin Inflammatory Bowel Disease Center Research Support: NIH/NIDDK, CCFA, BMRP Figure 2 Approach to Improve Outcomes for our IBD Patients
Epidemiology of IBD in Pediatric Patients in the US: Data from the ImproveCareNow Registry
Epidemiology of IBD in Pediatric Patients in the US: Data from the ImproveCareNow Registry Michael D. Kappelman, MD Professor of Pediatrics and Epidemiology University of North Carolina, Chapel Hill Richard
Optimizing the effectiveness of anti-tnf therapy in paediatric IBD
Optimizing the effectiveness of anti-tnf therapy in paediatric IBD Anne Griffiths MD, FRCPC Co-Lead, Inflammatory Bowel Disease Center Northbridge Chair in IBD Hospital for Sick Children, Professor of
COLONIC DISEASES PROBLEMS AND PROGRESS
THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (ESPGHAN) THE DEPARTMENT OF PEDIATRICS & THE EUROPEAN LABORATORY FOR THE INVESTIGATION OF FOOD INDUCED DISEASES, UNIVERSITY FEDERICO
Symposium 9. Evidence based or gut reaction
Symposium 9 Ch i E t l F d Choosing Enteral Feeds Evidence based or gut reaction All enteral feeds should contain fibre Ceri Green Global Medical Department Numico Clinical Nutrition Division Schiphol,
New treatment options in IBD: today and the future. Silvio Danese Istituto Clinico Humanitas, Milan, Italy
New treatment options in IBD: today and the future Silvio Danese Istituto Clinico Humanitas, Milan, Italy Date of preparation: October 2014 GLO/EYV/2014-00010h Overview of the late-stage IBD drug pipeline*
Infliximab (Remicade) for paediatric ulcerative colitis - second line
Infliximab (Remicade) for paediatric ulcerative colitis - second line September 2011 This technology summary is based on information available at the time of research and a limited literature search. It
Efficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,
Recent Advances in the Management of Refractory IBD
Recent Advances in the Management of Refractory IBD Raina Shivashankar, M.D. Assistant Professor of Medicine Division of Gastroenterology and Hepatology Thomas Jefferson University Philadelphia, PA Outline
Evaluation of treatment effect in UC and CD (children)
Evaluation of treatment effect in UC and CD (children) Dr Nick Croft Digestive Diseases, Centre for Immunobiology, Blizard Institute & Barts Health NHS Trust Blizard Institute Disclosures Dr Nick Croft
Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R.
UvA-DARE (Digital Academic Repository) Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R. Link to publication Citation for published version
Medical Therapy for Pediatric IBD: Efficacy and Safety
Medical Therapy for Pediatric IBD: Efficacy and Safety Betsy Maxwell, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Pediatric IBD: Defining Remission
An Overview on Pediatric Esophageal Disorders. Annamaria Staiano Department of Translational Medical Sciences University of Naples Federico II
An Overview on Pediatric Esophageal Disorders Annamaria Staiano Department of Translational Medical Sciences University of Naples Federico II Case report F.C. 3 year old boy Preterm born from emergency
Efficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,
Angelos Hatzakis. 10th Paris Hepatology Conference
Angelos Hatzakis Professor of Epidemiology and Preventive Medicine Faculty of Medicine National and Kapodistrian University of Athens Co-Chair, Hepatitis B and C Public Policy Association 10th Paris Hepatology
Fecal incontinence causes 196 epidemiology 8 treatment 196
Subject Index Achalasia course 93 differential diagnosis 93 esophageal dysphagia 92 95 etiology 92, 93 treatment 93 95 work-up 93 Aminosalicylates, pharmacokinetics and aging effects 36 Antibiotics diarrhea
Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014
Management and Medical Therapies for Crohn disease: strategies to enhance mucosal healing Anne Griffiths MD, FRCPC SickKids Hospital, University of Toronto Buenos Aires, August 16, 2014 New onset Crohn
2017 NEEDS ASSESSMENT SURVEY
2017 NEEDS ASSESSMENT SURVEY Quick Overview: Educational Topic Findings The online 2017 Needs Assessment survey was programmed through SurveyMonkey and a personalized request to complete the questionnaire
Welcome to the Pediatric Advanced Practice Provider Preceptorship!
Welcome to the Pediatric Advanced Practice Provider Preceptorship! This USB contains reading materials, information on how to complete the required three Virtual Preceptorships, and additional IBD educational
Diarrhea may be: Acute (short-term, usually lasting several days), which is usually related to bacterial or viral infections.
Pediatric Gastroenterology Conditions Evaluated and Treated Having a child suffer with abdominal pain, chronic eating problems, or other gastrointestinal disorders can be a very trying time for a parent.
Mucosal healing: does it really matter?
Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does it really matter? Professor Jean-Frédéric Colombel, New York, USA Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does
New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital
New treatment options in UC Rob Bryant IBD Consultant Royal Adelaide Hospital Talk Outline 1. Raising expectations 2. Optimising UC therapy 3. Clinical trials 4. What s new on the PBS? 5. Questions 1.
IBD in teenagers Biological and Transition
IBD in teenagers Biological and Transition Dr Warren Hyer Consultant Paediatric Gastroenterologist St Mark s Hospital Chelsea and Westminster Hospital Conflict of Interest None to declare Fee for presentation
Protocol for the management of acute severe ulcerative colitis in children
Protocol for the management of acute severe ulcerative colitis in children Introduction: Paediatric UC is severe and more extensive than adult onset UC with 6-8% presenting as pancolitis (1,2) Within five
IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital
IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital Aims To understand the aetiology of IBD To understand the impact that
NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL
NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL CROHN S DISEASE Chronic disease of uncertain etiology Etiology- genetic, environmental, and infectious Transmural
Inflammatory Bowel Disease Conference Friday, November 22, 2013
THE DR. STEPHEN MATARAZZO Inflammatory Bowel Disease Conference Friday, November 22, 2013 Seaview Hotel and Golf Resort Galloway, New Jersey 12 5:30pm Presented by This conference is made possible by a
Treatment of Pediatric IBD: What is Different?
Treatment of Pediatric IBD: What is Different? January 13, 2017 Michael Kappelman MD, MPH University of North Carolina at Chapel Hill Overview Is Pediatric IBD the same disease? Treatment considerations
ESPGHAN ESPEN Guidelines on Paediatric Parenteral Nutrition
ESPEN Congress Cannes 2003 Organised by the Israel Society for Clinical Nutrition Education and Clinical Practice Programme Session: Nutritional Guidelines: ESPEN and other Societies : TPN in Children:
PROGRAMME ESPGHAN BALTIC SUMMER SCHOOL SEPTEMBER 08 10, 2016 VILNIUS, LITHUANIA.
European Society for Paediatric Gastroenterology, Hepatology and Nutrition ESPGHAN BALTIC SUMMER SCHOOL SEPTEMBER 08 10, 2016 VILNIUS, LITHUANIA PROGRAMME EDUCATIONAL PARTNER PROGRAMME ESPGHAN provides
Systematic review with meta-analysis: early infant feeding and coeliac disease update 2015
Alimentary Pharmacology and Therapeutics Systematic review with meta-analysis: early infant feeding and coeliac disease update 2015 H. Szajewska*, R. Shamir, A. Chmielewska*, M. Piescik-Lech*, R. Auricchio,
SUSTAIN BASELINE DATA COLLECTION FORM. Revised 2/4/2014 (both pediatric and adult data elements) 1. Gestational age at birth ( weeks gestation)
SUSTAIN BASELINE DATA COLLECTION FORM Patient Demographics Revised 2/4/2014 (both pediatric and adult data elements) Did the patient begin Home PN over 90 days ago? Yes No Date began Home PN Patient Number
6TH INTERNATIONAL CONFERENCE ON NUTRITION & GROWTH THURSDAY, 7 MARCH 2019 Auditorium 1 Auditorium 2 Auditorium 3
6TH INTERNATIONAL CONFERENCE ON NUTRITION & GROWTH THURSDAY, 7 MARCH 2019 Before the first 1000 days: before conception and after birth 13:00-14:30 Chairs: Andrew Prentice and Kim F. Michaelsen Influence
190 Index Case studies, abdominal pain, 2 Crohn s disease, 2 3, cyclic vomiting syndrome (CVS), 2 fecal incontinence (FI), 2 medical c
Index Abdominal pain, case study, 2 Achalasia, 75 Acupuncture 108 American Academy of Pediatrics, 49 Anxiety, 8 9, 98 Autism, GI disorders and, 25 27 BASC. See Behavior Assessment System for Children (BASC)
Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.
Formulations and Availability S TU D I E S PE R D I S E A S E 39 LIVER Liver Disease, Cirrhosis, Liver Failure, Hepatic Encephalopathy S TU D I E S PE R AG E G RO U P Visbiome Regular Product Code: 693-0412-01
Complementary & Alternative Therapies in IBD
Complementary & Alternative Therapies in IBD Laurie Rosales, APRN-CNP OSU Wexner Medical Center Division of Gastroenterology, Hepatology and Nutrition Complementary & Alternative Probiotics Cannabis Fish
Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists
What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists Disclosures No financial relationships to disclose. 1 Learning Objectives Case 24M with ileocolonic
Corporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: fecal_calprotectin_test 8/2009 11/2017 11/2018 11/2017 Description of Procedure or Service Fecal calprotectin
Inflammatory bowel disease (IBD) Overview of the Paediatric investigation plans. Presented by: Richard Veselý. An agency of the European Union
Inflammatory bowel disease (IBD) Overview of the Paediatric investigation plans Presented by: Richard Veselý An agency of the European Union Adalimumab - Crohn s disease Indication: Treatment of severe,
Biologic Therapy for Ulcerative Colitis in 2015
5/6/215 Biologic Therapy for Ulcerative Colitis in 215 John K. Marshall MD MSc FRCPC AGAF Division of Gastroenterology McMaster University Bressler B, Marshall JK, et al. Gastroenterology 215;148: 135-58
8 th Congress of ECCO
European Crohn s and Colitis Organisation Vienna Austria 8 th Congress of ECCO Austria Center Vienna February 14-16, 2013 The major educational event in the field of Inflammatory Bowel Diseases in Europe
Access to treatment and disease burden
Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor
Michael D. Kreines, M.D.
Michael D. Kreines, M.D. Gastroenterology Section Chief Medical Director, IBD Program The Christ Hospital of Cincinnati Ohio GI and Liver Institute www.ohiogi.com This Year s Story How to figure out how
September 12, 2015 Millie D. Long MD, MPH, FACG
Update on Biologic Therapy in 2015 September 12, 2015 Millie D. Long MD, MPH, FACG Assistant Professor of Medicine Inflammatory Bowel Disease Center University of North Carolina-Chapel Hill Outline Crohn
IBD Updates. Themes in IBD IBD management journey. New tools for therapeutic monitoring. First-line treatment in IBD
IBD Updates Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida Themes in IBD 213 First-line treatment in IBD New tools for therapeutic monitoring Biologic therapy for CD and
Program Schedule Template Monday, February 23, 2015 Time Topic 7:00 a.m. Registration and Continental Breakfast 7:30 a.m. Welcome and Introductions
Program Schedule Template Monday, February 23, 2015 7:00 a.m. Registration and Continental Breakfast 7:30 a.m. Welcome and Introductions William Sanchez, M.D., Shabana F. Pasha, M.D. and Michael F. Picco,
Systematic review with meta-analysis: early infant feeding and coeliac disease update 2015
Alimentary Pharmacology and Therapeutics Systematic review with meta-analysis: early infant feeding and coeliac disease update 2015 H. Szajewska*, R. Shamir, A. Chmielewska*, M. Piescik-Lech*, R. Auricchio,
Nutrition as primary therapy in IBD. Dr Clare Donnellan Leeds General Infirmary
Nutrition as primary therapy in IBD Dr Clare Donnellan Leeds General Infirmary Case GB 34 year old female Diagnosed with Crohn s in 2002? Extent Offered steroids or surgery Declined both GB Represented
Looking for Answers. IBD Research March 9, Dr. Benjamin Click, MD MS Associate Staff Cleveland Clinic
Looking for Answers IBD Research 2019 March 9, 2019 Dr. Benjamin Click, MD MS Associate Staff Cleveland Clinic Disclosures No relevant financial disclosures There is still no cure for IBD Why me? ETIOLOGY
IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition
IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel
Key uncertainties around the evidence or technology are that the test has only been validated in biochemical studies.
pat hways PredictSure-IBD for inflammatory bowel disease prognosis Medtech innovation briefing Published: 25 March 2019 nice.org.uk/guidance/mib178 Summary The technology described in this briefing is
A Summary of Childhood Cancer Statistics in Australia,
What is the Australian Paediatric Cancer Registry (APCR)? The APCR is one of only a few national registries of childhood cancer in the world. It covers all Australian children aged 0-14 years old at diagnosis.
2017 Canadian Association of Gastroenterology Educational Needs Assessment Report
2017 Canadian Association of Gastroenterology Educational Needs Assessment Report Kevin A. Waschke MD., CM., FRCPC, FASGE VP Education Affairs, Canadian Association of Gastroenterology Karen Sparkes BASc
PROGRAMME PAEDIATRIC NUTRITION: BEYOND THE NUTRIENTS - SUMMER SCHOOL JUNE 25 30, 2017 BARI, ITALY.
European Society for Paediatric Gastroenterology, Hepatology and Nutrition PAEDIATRIC NUTRITION: BEYOND THE NUTRIENTS - JUNE 25 30, 2017 BARI, ITALY PROGRAMME European Society for Paediatric Gastroenterology,
Dr David Rowbotham. The Leeds Teaching Hospitals NHS Trust NHS
Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust NHS Useful Titbits from the World of Gastroenterology David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology
IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants
IBD Understanding Your Medications Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications (& Your Doctor) Thomas V. Aguirre, MD Santa Barbara GI Consultants Disclosure I
Managing IBD at the extremes of age: Transitioning Teens
Oxford Inflammatory Bowel Disease & Hepatology MasterClass Managing IBD at the extremes of age: Transitioning Teens Dr RM Beattie Consultant Paediatric Gastroenterologist Southampton Challenges in the
Gastroenterology Fellowship Program
Gastroenterology Fellowship Program Outpatient Clinical Rotations I. Overview A. Three Year Continuity Clinic Experience All gastroenterology fellows will be required to have a ½ day continuity clinic
Clinical Report: Probiotics and Prebiotics in Pediatrics
www.medscape.com Authors and Disclosures Author(s) Dan W. Thomas, MD Professor of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California; Head, Division of Gastroenterology
Extrapolation & Pediatric Development: A case study from pediatric Ulcerative Colitis Richard Strauss, MD
Extrapolation & Pediatric Development: A case study from pediatric Ulcerative Colitis Richard Strauss, MD Immunology Clinical Development Janssen Research and Development Agenda Rationale for extrapolation
The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Gastroenterology
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Gastroenterology 1. GOAL: Understand the role of the general pediatrician in the assessment and management of patients with
Differentiate IgE-mediated food allergy from non-ige mediated food allergy. List the foods and formulas most commonly associated with food allergy.
Gastroenterology Description: The resident will be exposed to various clinical symptoms and diseases of the gastrointestinal tract which are commonly seen by the gastroenterologist. The resident will be
Use of extrapolation in small clinical trials:
Use of extrapolation in small clinical trials: Infliximab for pediatric ulcerative colitis Jessica J. Lee, MD, MMSc Medical Officer Division of Gastroenterology and Inborn Errors Products CDER/ FDA 1 Learning
Iron requirements of infants and toddlers
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Iron requirements of infants and toddlers Domellöf, Magnus; Braegger,
IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition
IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel
This is the author s final accepted version.
Biskou, O., Gardner-Medwin, J., Mackinder, M., Bertz, M., Clark, C., Svolos, V., Russell, R. K., Edwards, C. A., McGrogan, P., and Gerasimidis, K. (2016) Faecal calprotectin in treated and untreated children
Faecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS)
Faecal Calprotectin Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS) Reliable, Non Invasive Identification of IBD vs IBS Available from Eurofins
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 3 October 2012 REMICADE 100 mg, powder for concentrate for solution for infusion B/1 vial (CIP code: 562 070-1) Applicant:
Synopsis. Adalimumab M Clinical Study Report R&D/09/060. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:
Synopsis Abbott Laboratories Name of Study Drug: Individual Study Table Referring to Part of Dossier: Volume: (For National Authority Use Only) Name of Active Ingredient: Page: Title of Study: A Multi-Center,
Improving outcome of Inflammatory Bowel Disease in children
Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University School of Medicine Pediatric Gastroenterology
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
Manuscript Doi: /ecco-jcc/jjx150
Differences in outcomes over time with exclusive enteral nutrition compared to steroids in children with mild to moderate Crohn's Disease: results from the GROWTH CD study Noa Cohen-Dolev 1#, Malgorata
Inflammatory Bowel Disease Output from India: A Scientometric Assessment of Publications during
Cronicon OPEN ACCESS EC GASTROENTEROLOGY AND DIGESTIVE SYSTEM Literature Review Inflammatory Bowel Disease Output from India: A Scientometric Assessment of Publications during 2007-18 BM Gupta* Formerly
CURRENT RESEARCH STUDIES (GI and Hepatology Clinical Research Office University of Wisconsin)
CURRENT RESEARCH STUDIES (GI and Hepatology Clinical Research Office University of Wisconsin) OPEN TO ENROLLMENT: Liver Studies Seroprevalence of Hepatitis E in Organ Transplant subjects PI: Michael Lucey
The revised Porto criteria for diagnosing
R E S E A R C H P A P E R Long-term Outcome of Inflammatory Bowel Disease Unclassified in Children SIBA PROSAD PAUL AND BHUPINDER KAUR SANDHU From Bristol Royal Hospital for Children, Upper Maudlin Street,
Adalimumab for Inflammatory Bowel Disease. An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Adalimumab for Inflammatory Bowel Disease An information guide Adalimumab for Inflammatory Bowel Disease (IBD) What is Adalimumab and how
Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases
Clinical Trials in IBD Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases Objectives Today s discussion will address the following topics: Similarities and differences between Crohn
Description of Commitment
AbbVie U.S. Postmarketing s Table: Name of ANDROGEL (testosterone gel) CREON (pancrelipase) CREON (pancrelipase) / 022309 and 021015 20725 20725 125057/0 125057/114 Description of A randomized, double-blind,
Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut
Clinically proven to quickly relieve symptoms of common gastrointestinal disorders GASTROINTESTINAL DISEASE Referred to as gastrointestinal diseases, they are common disorders which affect the esophagus,
Guided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv
Guided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv University 1 SHARE study My year Collaboration between gastroenterology
POSITION PAPER. and jjjjôô Christian Molgaard ABSTRACT. Copyright ESPGHAL and NASPGHAN. All rights reserved. What Is Known
POSITION PAPER Complementary Feeding: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition Mary Fewtrell, y Jiri Bronsky,
Clinical Policy: Fecal Calprotectin Assay Reference Number: CP.MP.135
Clinical Policy: Reference Number: CP.MP.135 Effective Date: 11/16 Last Review Date: 11/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
CURRICULUM VITAE. Date of Revision: 7/28/2014. Anthony F. Porto, M.D., M.P.H. Yale University School of Medicine. Education:
CURRICULUM VITAE Date of Revision: 7/28/2014 Name: School: Anthony F. Porto, M.D., M.P.H. Yale University School of Medicine Education: B.A. Columbia University, New York, NY 8/1993-5/1997 M.D. Tufts University
Eosinophilic Esophagitis. Another Reason Not to Swallow
Eosinophilic Esophagitis Another Reason Not to Swallow Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or
PAEDIATRIC GASTROENTEROLOGY SCHOOL OCTOBER 26-29, 2016 FLORENCE, ITALY PROGRAMME.
PAEDIATRIC GASTROENTEROLOGY SCHOOL OCTOBER 26-29, 2016 FLORENCE, ITALY PROGRAMME EDUCATIONAL PARTNER PROGRAMME provides a variety of educational activities, events and information that are available through
Predicting response to anti - integrin therapy: long term efficacy and roles for optimisation with vedolizumab.
Predicting response to anti - integrin therapy: long term efficacy and roles for optimisation with vedolizumab. Dr Peter Irving Guy s and St Thomas Hospital, London King s College London Response to vedolizumab